October 2, 2015
Vernalis Acquires U.S. Rights to Moxatag
Vernalis plc has announces that it has acquired the US rights to Moxatag (amoxicillin extended-release tablets) from Pragma Pharmaceuticals, LLC (“Pragma”).
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Pragma Pharmaceuticals